TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
NTRB

Nutriband Inc

Healthcare · Biotechnology

8.10$ +6.3% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns Nutriband Inc (NTRB)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 43.4% of the shares are freely tradable; institutional investors hold 3.1%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 3.1%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 71.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 43.4%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 3.3%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 12Mio.

Largest Shareholders

Institutions

Institutions NTRB
Name Stake (%) Shares Change (%) Date
Vanguard Capital Management, LLC 1.44 174,927 +0.0 03/31/2026
Geode Capital Management, LLC 0.58 70,053 +16.9 03/31/2026
UBS Group AG 0.27 32,664 +2,515.2 03/31/2026
Vanguard Fiduciary Trust Co 0.21 25,111 +0.0 03/31/2026
State Street Corp 0.21 24,966 +0.0 03/31/2026
Citadel Advisors Llc 0.16 18,996 +0.0 06/30/2026
Northern Trust Corp 0.11 13,945 +0.0 03/31/2026

Funds

Funds NTRB
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 1.01 122,586 +0.0 07/31/2026
Vanguard Institutional Extnd Mkt Idx Tr 0.43 52,341 +0.0 07/31/2026
Fidelity Extended Market Index 0.22 26,216 -0.2 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?